Literature DB >> 10350520

Biomarkers of environmental tobacco smoke exposure.

N L Benowitz1.   

Abstract

Biomarkers are desirable for quantitating human exposure to environmental tobacco smoke (ETS) and for predicting potential health risks for exposed individuals. A number of biomarkers of ETS have been proposed. At present cotinine, measured in blood, saliva, or urine, appears to be the most specific and the most sensitive biomarker. In nonsmokers with significant exposure to ETS, cotinine levels in the body are derived primarily from tobacco smoke, can be measured with extremely high sensitivity, and reflect exposure to a variety of types of cigarettes independent of machine-determined yield. Under conditions of sustained exposure to ETS (i.e., over hours or days), cotinine levels reflect exposure to other components of ETS. Supporting the validity of cotinine as a biomarker, cotinine levels have been positively correlated to the risks of some ETS-related health complications in children who are not cigarette smokers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350520      PMCID: PMC1566286          DOI: 10.1289/ehp.99107s2349

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  50 in total

1.  Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure.

Authors:  M J Jarvis; M A Russell; N L Benowitz; C Feyerabend
Journal:  Am J Public Health       Date:  1988-06       Impact factor: 9.308

2.  Home air nicotine levels and urinary cotinine excretion in preschool children.

Authors:  F W Henderson; H F Reid; R Morris; O L Wang; P C Hu; R W Helms; L Forehand; J Mumford; J Lewtas; N J Haley
Journal:  Am Rev Respir Dis       Date:  1989-07

3.  Absorption of nicotine and carbon monoxide from passive smoking under natural conditions of exposure.

Authors:  M J Jarvis; M A Russell; C Feyerabend
Journal:  Thorax       Date:  1983-11       Impact factor: 9.139

4.  Yields of tar, nicotine, and carbon monoxide in the sidestream smoke from 15 brands of Canadian cigarettes.

Authors:  W S Rickert; J C Robinson; N Collishaw
Journal:  Am J Public Health       Date:  1984-03       Impact factor: 9.308

5.  The use of biologic fluid samples in assessing tobacco smoke consumption.

Authors:  N L Benowitz
Journal:  NIDA Res Monogr       Date:  1983

6.  Passive smoking, salivary cotinine concentrations, and middle ear effusion in 7 year old children.

Authors:  D P Strachan; M J Jarvis; C Feyerabend
Journal:  BMJ       Date:  1989-06-10

7.  Prevalence and correlates of passive smoking.

Authors:  G D Friedman; D B Petitti; R D Bawol
Journal:  Am J Public Health       Date:  1983-04       Impact factor: 9.308

8.  Tobacco sidestream smoke: uptake by nonsmokers.

Authors:  D Hoffmann; N J Haley; J D Adams; K D Brunnemann
Journal:  Prev Med       Date:  1984-11       Impact factor: 4.018

9.  Smokers of low-yield cigarettes do not consume less nicotine.

Authors:  N L Benowitz; S M Hall; R I Herning; P Jacob; R T Jones; A L Osman
Journal:  N Engl J Med       Date:  1983-07-21       Impact factor: 91.245

10.  Biochemical markers of smoke absorption and self reported exposure to passive smoking.

Authors:  M Jarvis; H Tunstall-Pedoe; C Feyerabend; C Vesey; Y Salloojee
Journal:  J Epidemiol Community Health       Date:  1984-12       Impact factor: 3.710

View more
  110 in total

1.  Maternal smoking during pregnancy and severe antisocial behavior in offspring: a review.

Authors:  Lauren S Wakschlag; Kate E Pickett; Edwin Cook; Neal L Benowitz; Bennett L Leventhal
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

2.  Magnitude and Chronicity of Environmental Smoke Exposure Across Infancy and Early Childhood in a Sample of Low-Income Children.

Authors:  Lisa M Gatzke-Kopp; Michael T Willoughby; Siri M Warkentien; Thomas O'Connor; Douglas A Granger; Clancy Blair
Journal:  Nicotine Tob Res       Date:  2019-11-19       Impact factor: 4.244

3.  UGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption.

Authors:  Jeannette Zinggeler Berg; Linda B von Weymarn; Elizabeth A Thompson; Katherine M Wickham; Natalie A Weisensel; Dorothy K Hatsukami; Sharon E Murphy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

4.  Separating Family-Level and Direct Exposure Effects of Smoking During Pregnancy on Offspring Externalizing Symptoms: Bridging the Behavior Genetic and Behavior Teratologic Divide.

Authors:  Ryne Estabrook; Suena H Massey; Caron A C Clark; James L Burns; Brian S Mustanski; Edwin H Cook; T Caitlin O'Brien; Beth Makowski; Kimberly A Espy; Lauren S Wakschlag
Journal:  Behav Genet       Date:  2015-11-18       Impact factor: 2.805

5.  Comparison of parental reports of smoking and residential air nicotine concentrations in children.

Authors:  U Gehring; B P Leaderer; J Heinrich; M Oldenwening; M E C A Giovannangelo; E Nordling; G Merkel; G Hoek; T Bellander; B Brunekreef
Journal:  Occup Environ Med       Date:  2006-08-15       Impact factor: 4.402

6.  Are we underestimating the rates of incontinence after prostate cancer treatment? Results from NHANES.

Authors:  Michael Daugherty; Raju Chelluri; Gennady Bratslavsky; Timothy Byler
Journal:  Int Urol Nephrol       Date:  2017-07-14       Impact factor: 2.370

7.  Maternal-fetal attachment differentiates patterns of prenatal smoking and exposure.

Authors:  Suena H Massey; Margaret H Bublitz; Susanna R Magee; Amy Salisbury; Raymond S Niaura; Lauren S Wakschlag; Laura R Stroud
Journal:  Addict Behav       Date:  2015-01-20       Impact factor: 3.913

8.  Evaluation of the immediate impact of the Washington, D.C., smoke-free indoor air policy on bar employee environmental tobacco smoke exposure.

Authors:  Jennifer Pearson; Richard Windsor; Ayman El-Mohandes; David C Perry
Journal:  Public Health Rep       Date:  2009 Jul-Aug       Impact factor: 2.792

Review 9.  Methods used in internal industry clinical trials to assess tobacco risk reduction.

Authors:  Vaughan W Rees; Jennifer M Kreslake; Richard J O'Connor; K Michael Cummings; Mark Parascandola; Dorothy Hatsukami; Peter G Shields; Gregory N Connolly
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  ITC "spit and butts" pilot study: the feasibility of collecting saliva and cigarette butt samples from smokers to evaluate policy.

Authors:  Brian V Fix; Richard O'Connor; David Hammond; Bill King; Ann McNeill; James Thrasher; Marcelo Boado; K Michael Cummings; Hua-Hie Yong; Mary E Thompson; Andrew Hyland
Journal:  Nicotine Tob Res       Date:  2010-01-15       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.